Trial Profile
Phase I study of enzastaurin and temozolomide in patients with gliomas.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Enzastaurin (Primary) ; Temozolomide
- Indications Glioma
- Focus Adverse reactions
- 12 Sep 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
- 11 Feb 2011 New source identified and integrated (United Kingdom Clinical Research Network)
- 11 Feb 2011 Additional company (Eli Lilly) added as reported by United Kingdom Clinical Research Network.